Digital Innovations in Rheumatology: Dr. Paul Studenic on What’s Next After ACR and EULAR
This episode was recorded live in Berlin at the 7th Digital Rheumatology Days. We’re joined by Dr. Paul Studenic from the Medical University of Vienna, who brings key insights from the latest digital innovations presented at ACR and EULAR.
Together, we explore emerging trends in digital health, their real-world applications, and what’s likely to shape rheumatology care in the near future. From advances in patient empowerment and digital literacy to cutting-edge tools poised to transform clinical practice, we unpack what’s truly promising — and what could redefine the future of care.
If you’re curious about where digital rheumatology is headed, this episode offers forward-looking insights you won’t want to miss.
Paul Studenic MD PhD
Medical University of Vienna, Department of Internal Medicine 3, Division of Rheumatology
Karolinska Institutet, Department of Medicine (Solna), Division of Rheumatology
Paul Studenic is a senior consultant rheumatologist and principal investigator for clinical outcomes science at the Medical University of Vienna (MUV, Austria) as well as affiliated to research at the Karolinska Institutet in Stockholm (Sweden). Paul has been previously working as post-doc at the Karolinska Institutet in Stockholm, addressing questions on outcomes in people at-risk to develop RA. He has done his PhD in outcomes research of inflammatory arthritis with a special focus on patient-reported outcomes at the MUV. At the same institution he has also undergone his medical training. He is involved in several EULAR activities in education, Quality of Care and co-lead of the Big Data study group. Particularly within the EULAR School of Rheumatology he authored RMD courses and acts as medical advisor for the educational course of patient research partners. Further on, he has a special interest in possibilities of the integration of mobile apps into health care settings. He is engaged in several collaborative projects investigating novel technologies for better care pathways in people with rheumatoid arthritis.
Digital Innovations in Rheumatology: Dr. Paul Studenic on What’s Next After ACR and EULAR
If you like to get more intersting content please become a member or if you are already a member go to the member area directly: